Severe Immune Response Blood Test | EpiSwitch® COVID-19 Severity Test for SARS-CoV-2

EpiSwitch Covid Severity Test (CST) is an advanced blood test that helps you

Better understand your risk of a severe immune response to COVID-19

If You're ImmunocompromisedIf You're Anxious About Getting COVID-19Watch video to learn more
EpiSwitch CST assesses the risk that
COVID-19 poses to an individual.

Many people have questions about how the COVID-19 pandemic may affect them. “What will happen if I get infected?” “Will I have a severe immune response?” “Am I at risk for being hospitalized?”

EpiSwitch CST is the first and only commercially-available blood test to predict COVID-19 severity in ANY adult, independent of COVID-19 status. EpiSwitch CST is variant-agnostic, meaning that the test identifies risk due to regular SARS-CoV-2, as well as against the delta and omicron strains.

The test is designed to provide you and your healthcare provider (HCP) with actionable decision-making information to reduce your risk of negative COVID-19 related health outcomes based on your unique 3D genetic immune profile.

How EpiSwitch CST can help

Understanding YOUR risk of a severe immune response and potential for hospitalization is key to assisting you and your HCP’s strategy for avoiding infection, and making treatment decisions when necessary.

GAIN GREATER PEACE OF MIND

With so many uncertainties imposed by the COVID-19 pandemic, EpiSwitch CST identifies risk regardless of strain, including the delta and omicron variants.

IDENTIFY YOUR RISK OF DEVELOPING A SEVERE IMMUNE RESPONSE

With EpiSwitch CST you can go beyond the limits of basic clinical risk factors by understanding your personal immunogenetic risk.

INFORM PREVENTIVE LIFESTYLE DECISIONS

EpiSwitch CST provides critical information you can apply to everyday decisions to prevent infection.

EMPOWER VACCINATION DECISIONS

With multiple vaccine options now available, EpiSwitch CST can help you and your HCP make a vaccination plan.

INSTILL THE CONFIDENCE TO SAFELY RETURN TO WORK

"Should I return to work?" "Am I safer working from home?" Let EpiSwitch CST help guide your decision.

INFORM YOUR HCP’s ASSESSMENT

In combination with your HCP’s clinical assessment, EpiSwitch CST gives you the confidence to fully understand your level of risk.
Woman and young girl sitting together wearing blue face masks.

Features of EpiSwitch CST

EpiSwitch CST delivers essential information based on genetic markers to aid in determining an individual’s risk of severe immune response requiring critical care due to COVID-19.

EpiSwitch CST is the first and only prognostic blood test that can predict a severe immune response to future COVID-19 infection.

Helps identify individuals who would most likely require critical care.

Can be used by any adult, independent of their COVID-19 status––including those who have never been infected, those who have been infected, or those who are currently infected.

Conventional COVID-19 tests can only detect infection with SARS-CoV-2. They cannot predict whether an individual will have a severe immune response to COVID-19.

Knowledge of the EpiSwitch CST score allows HCPs and patients to formulate an effective management plan.

A molecular test from a routine blood draw with results in 48-72 hours.

The EpiSwitch CST report provides an
easy-to-understand assessment of risk for a severe immune response to COVID-19.

Sample results of EpiSwitch CST

EpiSwitch CST results provide an essential personalized measure of the risk of severe illness due to COVID-19.
 

Patient risk is presented as a single, easy-to-read EpiSwitch CST risk category, assessing the prognosis of patients if they become infected with SARS-CoV-2.

 

EpiSwitch CST includes clear guidance for interpretation of the risk category by a healthcare professional. Decisions on care and treatment should be based on the independent medical judgment of the treating HCP taking into consideration all available information.

Complete the Requisition Form and take it to your HCP today.

Patient FAQ